Medit wins four consecutive patent lawsuits against 3Shape
SEOUL, South Korea, Oct. 7, 2022 /PRNewswire/ -- Medit Corp. ("Medit"), a global provider of 3D scanning solutions, has successfully defended against four separate patent infringement actions filed in Germany by a Danish competitor, 3Shape A/S ("3Shape"). Over the past 3 years, 3Shape has aggressively pursued patent infringement actions against Medit based on four patents (EP 2,568,870; EP 2,400,919; EP 2,732,434; EP 3,401,876). However, all four patent lawsuits have now been concluded in Medit's favor by German courts. Moreover, 1 of the 4 patents were invalidated by German courts.
"We are delighted to find that the court confirmed these cases were without merit and also it was an attempt by the competitor to protect its preemptive position. We hope that this result helps discourage reckless legal disputes in the future. We see this as a victory for our customers and partners, and ultimately all those interested in digital dentistry. These rulings offer digital dentistry market a greater clarity and much needed security. Medit will continue to bring the best technology for the benefit of our customers and the patients." <GB Ko, CEO>
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, welcomes a new hospital performing the RefluxStoptm procedure in Italy, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone.
In late...
Hygiene and health company Essity is investing in a new global center for research and development, in Alsace, France, dedicated to tissue hygiene products. The state-of-the-art facility will focus on tissue to meet the evolving demands of branded...
Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to...
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful completion of the first two enrollments in the AMEND TS European pilot study. Dr. Bruno Melica and the team from Vila Nova de Gaia Hospital,...
Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the quarter ending March 31, 2024.
"We are executing our strategy of building on our partnered...
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today debuted the Best Ambulatory Surgery Centers ratings of outpatient surgical centers....
